The company announced that the Food and Drug Administration (FDA) has approved Journavx, a twice-daily pill that it described as a "highly selective NaV1.8 pain signal inhibitor for the treatment of ...

The healthcare sector has struggled to deliver worthwhile returns for investors since 2021, weighed down by several headwinds. Rising interest rates, challenges in the U.S. healthcare system, and the ...

CNBC’s Angelica Peebles and Vertex JournavxPharmaceuticals CEO Reshma Kewalramani join 'Squawk on the Street' to discuss the ...

Flash-Lite 2 can generate captions for around 40,000 unique images at a cost of less than a dollar on Google AI Studio’s paid ...

Google Photos will now add a SynthID watermark to the images edited using the Magic Editor. It aims to promote transparency and make it easier for people to identify AI manipulation.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth quarter and full year 2024 financial results on Monday, February 10, 2025 after the financial markets close. The company will ...

Google has officially launched Gemini 2.0, a significant update to its flagship AI model, aimed at enterprise users and ...

The cost-efficient model dubbed Gemini 2.0 Flash-Lite comes as a successor to the Gemini 1.5 Flash while sticking to the same ...

Mistral, the company sometimes considered Europe’s great hope for AI, is releasing several updates to its AI assistant, Le ...

Google Cloud's revenue grew 30% YoY in Q4'24 with margins up to 17.51%, driven by AI advancements. Discover their $75B ...

Google also released an experimental version of Gemini 2.0 Pro, the company’s flagship model with the best performance for ...